C

CIC Mauricie Inc. | Trois-Rivieres, Canada

Research site
(Unclaimed)
Location
700 Boul. Thibeau, Suite 200, Trois-Rivieres, Quebec, Canada
Site insights

Top conditions

Idiopathic Pulmonary Fibrosis (1 trial)

Pulmonary Fibrosis (1 trial)

Lung Diseases (1 trial)

Asthma (1 trial)

Interstitial Lung Diseases (1 trial)

Top treatments

BI 1015550

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

2 of 3
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

This study is open to adults with a lung disease called Idiopathic Pulmonary Fibrosis (IPF). People can join the study if they are 40 years or older....

Active, not recruiting
Idiopathic Pulmonary Fibrosis
Drug: Placebo
Drug: BI 1015550

This study is open to adults with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs). People who have a form of PF-ILD other than Idiopathic...

Active, not recruiting
Lung Diseases, Interstitial
Drug: Placebo
Drug: BI 1015550

Trial sponsors

Boehringer Ingelheim logo

Boehringer Ingelheim (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems